Back to User profile » Dr Dongyang Li
Papers published by Dr Dongyang Li:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
PF4V1, an miRNA-875-3p target, suppresses cell proliferation, migration, and invasion in prostate cancer and serves as a potential prognostic biomarker
Li D, Hao X, Dong Y, Zhang M, Song Y
Cancer Management and Research 2019, 11:2299-2312
Published Date: 21 March 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Prognostic value of serum alkaline phosphatase in the survival of prostate cancer: evidence from a meta-analysis
Li D, Lv H, Hao X, Hu B, Song Y
Cancer Management and Research 2018, 10:3125-3139
Published Date: 30 August 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients
Na Z, Qiao X, Hao X, Fan L, Xiao Y, Shao Y, Sun M, Feng Z, Guo W, Li J, Li J, Li D
OncoTargets and Therapy 2018, 11:4913-4944
Published Date: 20 August 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
An integrated analysis of key microRNAs, regulatory pathways and clinical relevance in bladder cancer
Li D, Hao X, Song Y
OncoTargets and Therapy 2018, 11:3075-3085
Published Date: 24 May 2018